Samsung Pharm (001360) — Cash Flow Quality Index
Samsung Pharm (001360) has a Cash Flow Quality Index of -0.01x as of June 2025. Operating cash flow of ₩-804.23 Million is below net income of ₩63.57 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore 001360 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Samsung Pharm Cash Flow Quality Index (2019–2019)
Historical Cash Flow Quality Index for Samsung Pharm across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see how efficiently does Samsung Pharm generate cash.
Annual Cash Flow Quality Index for Samsung Pharm (2019–2019)
Year-by-year earnings quality comparison for Samsung Pharm.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2019 | -0.35x | ₩-2.43 Billion | ₩6.89 Billion | — |